Skip to main content
NCBI home page
American Journal of Human Genetics logoLink to American Journal of Human Genetics
. 1995 Dec;57(6):1311–1317.

Phenylketonuria mutation analysis in Northern Ireland: a rapid stepwise approach.

J Zschocke 1, C A Graham 1, D J Carson 1, N C Nevin 1
PMCID: PMC1801432  PMID: 8533759

Abstract

We present a multistep approach for the rapid analysis of phenylketonuria (PKU) mutations. In the first step, three common mutations and a polymorphic short tandem repeat (STR) system are rapidly analyzed with a fluorescent multiplex assay. In the second step, minihaplotypes combining STR and VNTR data are used to determine rare mutations likely to be present in an investigated patient, which are then confirmed by restriction enzyme analysis. The remaining mutations are analyzed with denaturant gradient-gel electrophoresis and sequencing. The first two steps together identify both mutations in 90%-95% of PKU patients, and results can be obtained within 2 d. We have investigated 121 Northern Irish families with hyperphenylalaninemia, including virtually all patients born since 1972, and have found 34 different mutations on 241 of the 242 mutant alleles. Three mutations (R408W, I65T, and F39L) account for 57.5% of mutations, while 14 mutations occur with a frequency of 1%-6%. The present analysis system is efficient and inexpensive and is particularly well suited to routine mutation analysis in a diagnostic setting.

Full text

PDF
1311

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Cotton R. G., Howells D. W., Saleeba J. A., Dianzani I., Smooker P. M., Jennings I. G. Structure function studies of the phenylalanine hydroxylase active site and a summary of structural features. Adv Exp Med Biol. 1993;338:55–57. doi: 10.1007/978-1-4615-2960-6_10. [DOI] [PubMed] [Google Scholar]
  2. Eiken H. G., Odland E., Boman H., Skjelkvåle L., Engebretsen L. F., Apold J. Application of natural and amplification created restriction sites for the diagnosis of PKU mutations. Nucleic Acids Res. 1991 Apr 11;19(7):1427–1430. doi: 10.1093/nar/19.7.1427. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Eisensmith R. C., Woo S. L. Updated listing of haplotypes at the human phenylalanine hydroxylase (PAH) locus. Am J Hum Genet. 1992 Dec;51(6):1445–1448. [PMC free article] [PubMed] [Google Scholar]
  4. Goltsov A. A., Eisensmith R. C., Konecki D. S., Lichter-Konecki U., Woo S. L. Associations between mutations and a VNTR in the human phenylalanine hydroxylase gene. Am J Hum Genet. 1992 Sep;51(3):627–636. [PMC free article] [PubMed] [Google Scholar]
  5. Goltsov A. A., Eisensmith R. C., Naughton E. R., Jin L., Chakraborty R., Woo S. L. A single polymorphic STR system in the human phenylalanine hydroxylase gene permits rapid prenatal diagnosis and carrier screening for phenylketonuria. Hum Mol Genet. 1993 May;2(5):577–581. doi: 10.1093/hmg/2.5.577. [DOI] [PubMed] [Google Scholar]
  6. Guldberg P., Henriksen K. F., Güttler F. Molecular analysis of phenylketonuria in Denmark: 99% of the mutations detected by denaturing gradient gel electrophoresis. Genomics. 1993 Jul;17(1):141–146. doi: 10.1006/geno.1993.1295. [DOI] [PubMed] [Google Scholar]
  7. Guldberg P., Henriksen K. F., Thöny B., Blau N., Güttler F. Molecular heterogeneity of nonphenylketonuria hyperphenylalaninemia in 25 Danish patients. Genomics. 1994 May 15;21(2):453–455. doi: 10.1006/geno.1994.1296. [DOI] [PubMed] [Google Scholar]
  8. Guldberg P., Mikkelsen I., Henriksen K. F., Lou H. C., Güttler F. In vivo assessment of mutations in the phenylalanine hydroxylase gene by phenylalanine loading: characterization of seven common mutations. Eur J Pediatr. 1995 Jul;154(7):551–556. doi: 10.1007/BF02074833. [DOI] [PubMed] [Google Scholar]
  9. Jennings I. G., Kemp B. E., Cotton R. G. Localization of cofactor binding sites with monoclonal anti-idiotype antibodies: phenylalanine hydroxylase. Proc Natl Acad Sci U S A. 1991 Jul 1;88(13):5734–5738. doi: 10.1073/pnas.88.13.5734. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Okano Y., Eisensmith R. C., Güttler F., Lichter-Konecki U., Konecki D. S., Trefz F. K., Dasovich M., Wang T., Henriksen K., Lou H. Molecular basis of phenotypic heterogeneity in phenylketonuria. N Engl J Med. 1991 May 2;324(18):1232–1238. doi: 10.1056/NEJM199105023241802. [DOI] [PubMed] [Google Scholar]
  11. Weber J. L., Wong C. Mutation of human short tandem repeats. Hum Mol Genet. 1993 Aug;2(8):1123–1128. doi: 10.1093/hmg/2.8.1123. [DOI] [PubMed] [Google Scholar]
  12. Zschocke J., Carson D. J. Transient neonatal hyperphenylalaninaemia is not related to mutations at the phenylalanine hydroxylase gene. J Inherit Metab Dis. 1995;18(3):369–370. doi: 10.1007/BF00710439. [DOI] [PubMed] [Google Scholar]
  13. Zschocke J., Graham C. A., McKnight J. J., Nevin N. C. The STR system in the human phenylalanine hydroxylase gene: true fragment length obtained with fluorescent labelled PCR primers. Acta Paediatr Suppl. 1994 Dec;407:41–42. doi: 10.1111/j.1651-2227.1994.tb13447.x. [DOI] [PubMed] [Google Scholar]
  14. Zschocke J., Graham C. A., Stewart F. J., Carson D. J., Nevin N. C. Automated sequencing detects all mutations in Northern Irish patients with phenylketonuria and mild hyperphenylalaninaemia. Acta Paediatr Suppl. 1994 Dec;407:37–38. doi: 10.1111/j.1651-2227.1994.tb13445.x. [DOI] [PubMed] [Google Scholar]

Articles from American Journal of Human Genetics are provided here courtesy of American Society of Human Genetics

RESOURCES